Gauthier S., Juby A., Rehel B., Schecter R. (2007). EXACT: rivastigmine improves the high prevalence of attention deficits and mood and behaviour symptoms in Alzheimer's disease, Int J Clin Pract, 61(6), 886-95.

Gauthier S., Poirier J. (2007). Maladie d’Alzheimer . In Arcand M. & Hébert R. (Eds.) , Précis de Gériatrie (pp. 257-266). Edisem Inc..

Gauthier S., Poirier J. (2007). Survol des facteurs génétiques et de quelques enjeux éthiquers liés à la maladie d’Alzheimer, L’Observatoire de la génétique, www.ircm.qc.ca/bioéthique/obsgenetique, Fev/Mars.

Gauthier S., Thal L. L., Rossor M. N. (2007). Future diagnosis and management of Alzheimer’s disease . In Gauthier S. (Ed.) , Clinical Diagnosis and Management of Alzheimer’s Disease (pp. 379-382). Informa Health Care.

Harvey P. O., Pruessner J., Czechowska Y., Lepage M. (2007). Individual differences in trait anhedonia: a structural and functional magnetic resonance imaging study in non-clinical subjects, Mol Psychiatry, 12(8), 703, 767-75.

Herrmann N., Gauthier S., Lysy P. G. (2007). Clinical practice guidelines for severe Alzheimer's disease, Alzheimer's Demen, 3(4), 385-397.

Hupbach A., Hardt O., Nadel L., Bohbot V. (2007). Spatial reorientation: Effects of verbal and spatial shadowing, Spat Cogn Comput, 7, 213-226.

Krantic S., Mechawar N., Reix S., Quirion R. (2007). Apoptosis-inducing factor: a matter of neuron life and death, Prog Neurobiol, 81(3), 179-96.

Leh S. E., Ptito A., Chakravarty M., Strafella A. P. (2007). Fronto-striatal connections in the human brain: a probabilistic diffusion tractography study, Neurosci Lett, 419(2), 113-8. Find out more.

Lupien S. J., Evans A., Lord C., Miles J., Pruessner M., Pike B., Pruessner J. (2007). Hippocampal volume is as variable in young as in older adults: implications for the notion of hippocampal atrophy in humans, Neuroimage, 34(2), 479-85.

Ma W., Quirion R. (2007). Inflammatory mediators modulating the transient receptor potential vanilloid 1 receptor: therapeutic targets to treat inflammatory and neuropathic pain, Expert Opin Ther Targets, 11(3), 307-20.

Mechawar N., Lacoste B., Yu W. F., Srivastava L., Quirion R. (2007). Developmental profile of neuregulin receptor ErbB4 in postnatal rat cerebral cortex and hippocampus, Neuroscience, 148(1), 126-39.

Peters K. R., Rockwood K., Black S. E., Hogan D. B., Gauthier S., Loy-English I., Hsiung G. Y., Jacova C., Kertesz A., Feldman H. H. (2007). Neuropsychiatric Symptom Clusters and Functional Disability in Cognitively-Impaired-Not-Demented Individuals, Am J Geriatr Psychiatry.

Petit-Turcotte C., Aumont N., Blain J. F., Poirier J. (2007). Apolipoprotein E receptors and amyloid expression are modulated in an apolipoprotein E-dependent fashion in response to hippocampal deafferentation in rodent, Neuroscience, 150(1), 58-63.

Poirier J. (2007). Apolipoprotein E: a potent gene-based therapeutic target for the treatment sporadic Alzheimer’s disease . In Cuello C. (Ed.) , Pharmacological and Mechanisms in Alzheimer's Therapeutic (pp. 212-222). Springer.

Poirier J. (2007). Cholesterol Transport and Production In Alzheimer's Disease . In Fisher. A. & Hanin I. (Eds.) , Advances In Behavioral Biology (pp. 101-106). Plenum Publishers.

Pruessner M., Pruessner J., Hellhammer D. H., Bruce Pike G., Lupien S. J. (2007). The associations among hippocampal volume, cortisol reactivity, and memory performance in healthy young men, Psychiatry Res, 155(1), 1-10.

Reix S., Mechawar N., Susin S. A., Quirion R., Krantic S. (2007). Expression of cortical and hippocampal apoptosis-inducing factor (AIF) in aging and Alzheimer's disease, Neurobiol Aging, 28(3), 351-6.

Rockwood K., Moorhouse P. K., Song X., MacKnight C., Gauthier S., Kertesz A., Montgomery P., Black S., Hogan D. B., Guzman A., Bouchard R., Feldman H. (2007). Disease progression in vascular cognitive impairment: cognitive, functional and behavioural outcomes in the Consortium to Investigate Vascular Impairment of Cognition (CIVIC) cohort study, J Neurol Sci, 252(2), 106-12.

Seow D., Gauthier S. (2007). Pharmacotherapy of Alzheimer disease, Can J Psychiatry, 52(10), 620-9.